Israel - English - Ministry of Health

megapharm ltd - carmustine - wafer - carmustine 7.7 mg - carmustine - carmustine - for use as an adjunct to surgery to prolong survival in patients with recurrent glioblastoma multiforme for whom surgical resection is indicated. gliadel implant is indicated in newly-diagnosed high-grade malignant glioma patients as an adjunct to surgery and radiation. gliadel implant is indicated for use as an adjunct to surgery in patients with recurrent histogically proved glioblastoma multiforme for whom surgical resection is indicated.

Singapore - English - HSA (Health Sciences Authority)

advagen pte. ltd. - carmustine - injection, powder, for solution - carmustine 100 mg/ vial

Australia - English - Department of Health (Therapeutic Goods Administration)

eisai australia pty ltd - carmustine, quantity: 7.7 mg - implant - excipient ingredients: polifeprosan - gliadel is indicated in newly-diagnosed high-grade malignant glioma patients as an adjunct to surgery and radiation. gliadel is also indicated for use as an adjunct to surgery to prolong survival in patients with recurrent glioblastoma multiforme (gbm) for whom surgical resection is indicated.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

emcure pharma uk ltd - carmustine - powder and solvent for solution for injection - 100mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

tillomed laboratories ltd - carmustine - powder and solvent for solution for injection - 100mg

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

navinta llc, united states - carmustine - powder and solvent for solution for infusion - 100 mg

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع أدوية البيدر الدولي - baider international drug store - carmustine 100 mg/1 vil - 100 mg/1 vil

Singapore - English - HSA (Health Sciences Authority)

alliance pharm pte. ltd. - carmustine - implant - 7.7mg - carmustine 7.7mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

clinigen healthcare ltd - carmustine - prolonged-release intralesional implant - 7.7mg

Ireland - English - HPRA (Health Products Regulatory Authority)

mgi pharma gmbh - carmustine - implant - 7.7 milligram(s) - nitrosoureas; carmustine